ABBVIE BAHAMAS LTD.;ABBVIE IRELAND UNLIMITED COMPANY
发明人:
申请号：
IL22649013
公开号：
IL226490A
申请日:
2013.05.21
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-x L .
